Urinary excretion of methylated purines in man and in the rat after the administration of theophylline.
Chromatographic characteristics of urinary metabolites of theophylline were studied by two-dimensional thin-layer chromatography, high-performance liquid chromatography and gas chromatography--mass spectrometry. Quantitative date for the urinary metabolites of theophylline in asthmatic children are given. It was shown that 1,3-dimethyluric acid is the predominant excretory product. In addition, smaller amounts of 1-methyluric acid, 3-methylxanthine and unchanged theophylline were found. Excretory patterns after theophylline ingestion before and during the administration of allopurinol in asthma patients and in rats suggest the existence of three metabolic pathways of theophylline. The administration of this drug to a patient with xanthine oxidase of theophylline. The administration of this drug to a patient with xanthine oxidase deficiency resulted in the excretion of 1-methyluric acid in addition to 1,3-dimethyluric acid, 3-methylxanthine, 1-methylxanthine and unchanged theophylline. It was concluded that in man the oxidation of theophylline is not catalysed by xanthine oxidase.
D000493:Allopurinol / Q000627:therapeutic use; D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000652:urine; D002648:Child; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D002855:Chromatography, Thin Layer / Q000379:methods; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods; D006801:Humans; D008297:Male; D011687:Purines / Q000652:urine*; D051381:Rats; D013806:Theophylline / Q000378:metabolism* / Q000627:therapeutic use; D014969:Xanthine Oxidase / Q000172:deficiency
D011687:Purines; D000493:Allopurinol; D013806:Theophylline; D014969:Xanthine Oxidase